TS
Third Security Portfolio holdings
AUM
$241M
This Quarter Return
+19.22%
1 Year Return
-45.43%
3 Year Return
-28.24%
5 Year Return
-58.7%
10 Year Return
–
AUM
$1.54B
AUM Growth
+$1.54B
(+24%)
Cap. Flow
+$47.5M
Cap. Flow
% of AUM
3.09%
Top 10 Holdings %
Top 10 Hldgs %
99.49%
Holding
17
New
3
Increased
1
Reduced
3
Closed
–
Top Buys
| 1 |
Precigen
PGEN
|
$132M |
| 2 |
PTC Therapeutics
PTCT
|
$6.47M |
| 3 |
Quaker Houghton
KWR
|
$261K |
| 4 |
Emergent Biosolutions
EBS
|
$251K |
Top Sells
| 1 |
Halozyme
HALO
|
$58.1M |
| 2 |
Theriva Biologics
TOVX
|
$33.4M |
| 3 |
Precipio
PRPO
|
$328K |
Sector Composition
| 1 | Healthcare | 94.62% |
| 2 | Energy | 3.53% |
| 3 | Consumer Staples | 1.57% |
| 4 | Materials | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Precigen
PGEN
$1.34B
| $1.15B | 74.98% | 66,993,639 +7,683,833 | +13% | +$132M |
|
|
2
Halozyme
HALO
$8.56B
| $256M | 16.64% | 14,092,771 -3,195,679 | -18% | -$58.1M |
|
3
Enterprise Products Partners
EPD
$69.6B
| $32.6M | 2.12% | 1,135,734 | – | – |
|
4
Alaunos Therapeutics
TCRT
$4.21M
| $31.1M | 2.02% | 9,709,607 | – | – |
|
5
AquaBounty Technologies
AQB
$4.58M
| $24.2M | 1.57% | 7,538,292 | – | – |
|
6
Energy Transfer Partners
ET
$60.8B
| $14.8M | 0.96% | 847,650 | – | – |
|
|
7
PTC Therapeutics
PTCT
$3.92B
| $6.47M | 0.42% | +137,551 | New | +$6.47M |
|
|
NS
8
DELISTED
NuStar Energy L.P.
NS
| $4.04M | 0.26% | 145,200 | – | – |
|
|
ETP
9
DELISTED
Energy Transfer Partners, L.P.
ETP
| $3.94M | 0.26% | 176,828 | – | – |
|
|
FCSC
10
DELISTED
Fibrocell Science Inc.
FCSC
| $3.9M | 0.25% | 1,653,486 | – | – |
|
|
TCP
11
DELISTED
TC Pipelines LP
TCP
| $2.94M | 0.19% | 97,000 | – | – |
|
12
Oragenics
OGEN
$4.25M
| $1.78M | 0.12% | 1,548,166 | – | – |
|
13
Ocugen
OCGN
$319M
| $1.47M | 0.1% | 2,690,570 | – | – |
|
|
14
Theriva Biologics
TOVX
$3.94M
| $983K | 0.06% | 378,239 -12,860,029 | -97% | -$33.4M |
|
|
15
Quaker Houghton
KWR
$2.52B
| $261K | 0.02% | +1,290 | New | +$261K |
|
|
16
Emergent Biosolutions
EBS
$443M
| $251K | 0.02% | +3,810 | New | +$251K |
|
|
17
Precipio
PRPO
$25.1M
| $209K | 0.01% | 529,405 -829,716 | -61% | -$328K |
|